Global Fatty Liver Treatment Industry Outlook 2025-2029: Market Set to Cross $32.98 Billion Milestone

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Fatty Liver Treatment Market Size By 2025?
The global market addressing fatty liver treatment has experienced robust expansion recently, projected to advance from its 2024 valuation of $23.73 billion to $25.05 billion in 2025, reflecting a steady compound annual growth rate of 5.5%; this upward trajectory during the historical period stems from several key factors, including the widespread obesity epidemic, increasingly sedentary daily routines, consumption of poor dietary choices, the scarcity of available therapeutic interventions, and heightened public campaigns aimed at raising awareness.

How Big Is the Fatty Liver Treatment Market Size Expected to Grow by 2029?
Projections indicate the market dedicated to treating fatty liver disease anticipates robust expansion ahead, reaching a valuation of $32.98 billion by 2029, propelled by a compound annual growth rate of 7.1%; this upward trajectory is founded upon escalating occurrences of the disorder, greater spending in healthcare sectors, the simultaneous rise of diabetes and metabolic syndrome, and ongoing advancements in pharmaceutical interventions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Which Key Market Drivers Powering Fatty Liver Treatment Market Expansion and Growth?
Elevated intake of alcoholic beverages, which feature alcohol as a mind-dulling psychoactive compound affecting the central nervous system, is poised to fuel the progression of the fatty liver treatment sector moving ahead. This intake of alcohol has the potential to exacerbate existing fatty liver conditions, potentially culminating in more critical liver ailments such as alcoholic fatty liver ailment or alcoholic hepatitis. As an illustration, evidence from March 2023, sourced from the HRB National Drugs Library-a publicly financed entity operating out of Ireland-indicated that Scotland witnessed a per capita consumption of 10.2 liters of pure alcohol among persons aged fifteen and above in 2022, marking a 7.6 percent augmentation from the preceding year, 2021, thus spotlighting a worrisome pattern of increased alcohol ingestion despite concurrent public health initiatives aimed at curbing its use. Consequently, this growing consumption of alcohol acts as a catalyst for the expansion within the market dedicated to treating fatty liver disease.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Fatty Liver Treatment Market?
A significant current sweeping across the fatty liver treatment landscape involves prioritizing product invention, with key players actively introducing novel offerings to bolster their competitive standing. As an illustration of this momentum, in March of 2023, Akero Therapeutics, a biotechnology firm based in the United States, announced encouraging results from their Phase II trials for efruxifermin, a therapeutic candidate aimed at patients diagnosed non-invasively with both nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). This agent functions as a distinct Fc-FGF21 fusion protein designed to replicate the natural functionality of fibroblast growth factor 21 (FGF21), a crucial element in controlling various metabolic sequences and cellular operations.

What Are the Emerging Segments in the Fatty Liver Treatment Market?
The fatty liver treatmentmarket covered in this report is segmented -

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants; Chemotherapy Drugs; Targeted Therapy; Vaccines; Anti-Viral Drugs
2) By Disease Type: Hepatitis; Liver Cancer; Non-Alcoholic Fatty Liver Disease; Other Diseases
3) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users

Subsegments:
1) By Anti-Rejection Drugs Or Immunosuppressants: Corticosteroids; Calcineurin Inhibitors; mTOR Inhibitors
2) By Chemotherapy Drugs: Conventional Chemotherapy Agents; Novel Chemotherapeutics Under Investigation
3) By Targeted Therapy: Small Molecule Inhibitors; Monoclonal Antibodies
4) By Vaccines: Therapeutic Vaccines; Preventive Vaccines
5) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs); Nucleos(t)ide Analogs

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12581&type=smp

Who Are the Global Leaders in the Fatty Liver Treatment Market?
Major companies operating in the fatty liver treatment market include Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

Which are the Top Profitable Regional Markets for the Fatty Liver Treatment Industry?
North America was the largest region in the fatty liver treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12581

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.